abstract |
Compounds and methods are provided for the relief or treatment of diseases or conditions in which the modification of the activity of the muscarinic receptor m1 has a beneficial effect. In the method, a therapeutically effective amount of the m1 muscarinic agonist selective compound is administered to a patient in need of such treatment. |